+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Theravance Biopharma - logo

Theravance Biopharma is a biopharmaceutical company that develops and commercializes human therapeutics. The company offers VIBATIV (telavancin), a bactericidal, once-daily injectable antibiotic. In addition, it has numerous product candidates, including Revefenacin (TD-4208), Axelopran, Velusetrag, TD-6450 and others. It also focuses on various drug development programs, including the combination of fluticasone furoate, umeclidinium, and vilanterol. Founded in 2013, it is based in George Town, the Cayman Islands.

Hypertension Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Hypertension Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • November 2022
  • 589 Pages
  • Global
From
Neprilysin - Pipeline Review, H2 2019 - Product Thumbnail Image

Neprilysin - Pipeline Review, H2 2019

  • Drug Pipelines
  • December 2019
  • 74 Pages
  • Global
From
Global Pneumatic Nebulizers Market Analysis & Forecast to 2024-2034 - Product Thumbnail Image

Global Pneumatic Nebulizers Market Analysis & Forecast to 2024-2034

  • Report
  • January 2024
  • 200 Pages
  • Global
From
Ulcerative Colitis - Pipeline Review, H2 2020 - Product Thumbnail Image

Ulcerative Colitis - Pipeline Review, H2 2020

  • Drug Pipelines
  • October 2020
  • 779 Pages
  • Global
From
Celiac Disease - Pipeline Review, H2 2020 - Product Thumbnail Image

Celiac Disease - Pipeline Review, H2 2020

  • Drug Pipelines
  • September 2020
  • 96 Pages
  • Global
From
Co-development Deals in Pharmaceuticals and Biotechnology 2016 to 2024 - Product Thumbnail Image

Co-development Deals in Pharmaceuticals and Biotechnology 2016 to 2024

  • Report
  • March 2024
  • 400 Pages
  • Global
From
Crohn's Disease (Regional Enteritis) - Pipeline Review, H2 2020 - Product Thumbnail Image

Crohn's Disease (Regional Enteritis) - Pipeline Review, H2 2020

  • Drug Pipelines
  • August 2020
  • 693 Pages
  • Global
From
Option and Evaluation Deals in Pharmaceuticals and Biotechnology 2016-2024 - Product Thumbnail Image

Option and Evaluation Deals in Pharmaceuticals and Biotechnology 2016-2024

  • Report
  • March 2024
  • 700 Pages
  • Global
From
Active Pharmaceutical Ingredient (API) Global Market - Forecast To 2027 - Product Thumbnail Image

Active Pharmaceutical Ingredient (API) Global Market - Forecast To 2027

  • Report
  • March 2021
  • 702 Pages
  • Global
From
Asset Purchase Deals in Pharmaceuticals and Biotechnology 2016-2024 - Product Thumbnail Image

Asset Purchase Deals in Pharmaceuticals and Biotechnology 2016-2024

  • Report
  • March 2024
  • 300 Pages
  • Global
From
Gastroparesis Drugs - Global Strategic Business Report - Product Thumbnail Image

Gastroparesis Drugs - Global Strategic Business Report

  • Report
  • May 2024
  • 197 Pages
  • Global
From
Gastroparesis Disease - Global Clinical Trials Review, H2 2020 - Product Thumbnail Image

Gastroparesis Disease - Global Clinical Trials Review, H2 2020

  • Clinical Trials
  • October 2020
  • 142 Pages
  • Global
From
Antiviral Drugs Market by Mechanism of Action, Target Indication, Type of Drug Target, Type of Therapy and Key Geographies: Industry Trends and Global Forecasts, 2022-2035 - Product Thumbnail Image

Antiviral Drugs Market by Mechanism of Action, Target Indication, Type of Drug Target, Type of Therapy and Key Geographies: Industry Trends and Global Forecasts, 2022-2035

  • Report
  • September 2022
  • 194 Pages
  • Global
From
Chronic Kidney Disease Market: Pipeline Review, Developer Landscape and Competitive Insights - Product Thumbnail Image

Chronic Kidney Disease Market: Pipeline Review, Developer Landscape and Competitive Insights

  • Report
  • November 2018
  • 164 Pages
  • Global
From
Autoimmune Collaboration and Licensing Deals 2016-2024 - Product Thumbnail Image

Autoimmune Collaboration and Licensing Deals 2016-2024

  • Report
  • April 2024
  • 500 Pages +
  • Global
From
Antibody Drug Conjugate Market (7th Edition): Distribution by Target Disease Indication, Therapeutic Area, Linker, Payload, Target Antigens And Key Geographical Regions (North America, Europe, and Asia-Pacific): Industry Trends and Global Forecasts, 2023-2035 - Product Thumbnail Image

Antibody Drug Conjugate Market (7th Edition): Distribution by Target Disease Indication, Therapeutic Area, Linker, Payload, Target Antigens And Key Geographical Regions (North America, Europe, and Asia-Pacific): Industry Trends and Global Forecasts, 2023-2035

  • Report
  • July 2023
  • 716 Pages
  • Global
From
Acute Heart Failure Global Clinical Trials Review, H2, 2019 - Product Thumbnail Image

Acute Heart Failure Global Clinical Trials Review, H2, 2019

  • Clinical Trials
  • December 2019
  • 181 Pages
  • Global
From
Global Gastroparesis Drugs Market by Drug Class (Anti-Emetic Agents, Botulinum Toxin Injections, Prokinetic Agents), Indication (Diabetic Gastroparesis, Idiopathic Gastroparesis, Post-surgical Gastroparesis), Sales Channel - Forecast 2024-2030 - Product Thumbnail Image

Global Gastroparesis Drugs Market by Drug Class (Anti-Emetic Agents, Botulinum Toxin Injections, Prokinetic Agents), Indication (Diabetic Gastroparesis, Idiopathic Gastroparesis, Post-surgical Gastroparesis), Sales Channel - Forecast 2024-2030

  • Report
  • March 2024
  • 199 Pages
  • Global
From
Mu Antagonist - Pipeline Insight, 2024 - Product Thumbnail Image

Mu Antagonist - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
Global Gastroparesis Drugs Market 2024-2028 - Product Thumbnail Image

Global Gastroparesis Drugs Market 2024-2028

  • Report
  • October 2023
  • 166 Pages
  • Global
From
Loading Indicator